Allarity Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Allarity Therapeutics Operating Expenses Growth & History (ALLR)
Allarity Therapeutics's operating expenses was $12.9M for fiscal 2025.
View full Allarity Therapeutics company overviewAllarity Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $12.9M | −$14.3M | −52.55% |
| 2024 | 2024-12-31 | $27.2M | $10.1M | +59.03% |
| 2023 | 2023-12-31 | $17.1M | −$17.3M | −50.30% |
| 2022 | 2022-12-31 | $34.5M | $7.9M | +29.77% |
| 2021 | 2021-12-31 | $26.6M | $18.2M | +219.22% |
| 2020 | 2020-12-31 | $8.3M | — | — |
Allarity Therapeutics quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.7M | −$1.5M | −35.37% |
| Q1 2026 | 2026-03-31 | $2.7M | −$323,000 | −10.64% |
| Q4 2025 | 2025-12-31 | $3.2M | −$4.1M | −55.75% |
| Q3 2025 | 2025-09-30 | $2.5M | −$9.8M | −79.55% |
| Q2 2025 | 2025-06-30 | $4.1M | $762,000 | +22.60% |
| Q1 2025 | 2025-03-31 | $3.0M | −$1.2M | −28.40% |
| Q4 2024 | 2024-12-31 | $7.3M | $2.4M | +49.97% |
| Q3 2024 | 2024-09-30 | $12.3M | $7.9M | +178.20% |
| Q2 2024 | 2024-06-30 | $3.4M | −$785,000 | −18.89% |
| Q1 2024 | 2024-03-31 | $4.2M | $572,000 | +15.59% |
| Q4 2023 | 2023-12-31 | $4.9M | −$1.9M | −27.72% |
| Q3 2023 | 2023-09-30 | $4.4M | −$136,000 | −2.98% |
| Q2 2023 | 2023-06-30 | $4.2M | −$686,000 | −14.17% |
| Q1 2023 | 2023-03-31 | $3.7M | −$14.6M | −79.97% |
| Q4 2022 | 2022-12-31 | $6.8M | −$9.0M | −57.13% |
| Q3 2022 | 2022-09-30 | $4.6M | $588,000 | +14.80% |
| Q2 2022 | 2022-06-30 | $4.8M | $466,000 | +10.65% |
| Q1 2022 | 2022-03-31 | $18.3M | $15.8M | +643.66% |
| Q4 2021 | 2021-12-31 | $15.7M | — | — |
| Q3 2021 | 2021-09-30 | $4.0M | $2.2M | +128.65% |
| Q2 2021 | 2021-06-30 | $4.4M | — | — |
| Q1 2021 | 2021-03-31 | $2.5M | — | — |
| Q3 2020 | 2020-09-30 | $1.7M | — | — |
Allarity Therapeutics operating expenses trends
Over the last five fiscal years, Allarity Therapeutics's operating expenses increased from $8.3M to $12.9M, a change of $4.6M. The latest reported quarter, Q2 2026, shows $2.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Allarity Therapeutics source filings ↗